PressDigest

J&J closes in on Pharmacyclics takeover

Johnson & Johnson is learnt to be in advanced discussions to buy US cancer drugmaker Pharmacyclics, in a potential blockbuster deal that would mark the latest chapter in the ongoing consolidation of the global healthcare industry.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump